Transition metal-doped iron oxide nanocrystals modulate MRI contrast performance

FDA-approved iron oxide nanocrystals (IONs) as negative magnetic resonance imaging (MRI) contrast agents are encountering challenges because of their low relaxation rate and coherent ferromagnetism. Although metal doping has been found as an efficient way to improve the magnetic property and MRI contrast performance, the systemic mechanism has been rarely discussed.


Related Posts

Leave a Reply

Your email address will not be published. Required fields are marked *

Generated by Feedzy